Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2025-12-25 @ 2:06 PM
NCT ID:
NCT00470366
Group ID:
EG000
Title:
Paclitaxel, Ifosfamide, and Cisplatin
Description:
-Paclitaxel is administered first, 120 mg/m2 on days 1 and 2 every three weeks for four cycles. Cisplatin is administered at 20 mg/m2 over approximately 30 minutes daily for five days every three weeks for four courses. -The ifosfamide is given last with 1200 mg/m2 daily for five days every three weeks for four cycles.
pegfilgrastim
cisplatin
ifosfamide
paclitaxel
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
34
Serious Number At Risk:
60
Other Number Affected:
60
Other Number At Risk:
60
Study:
NCT00470366
Results Section:
NCT00470366
Adverse Events Module:
NCT00470366